Homocysteine Impairs Endothelial Wound Healing by Activating Metabotropic Glutamate Receptor 5

Microcirculation

Volumn 19, Issue 4, 2012, Pages 285-295

  Chen, Cheng Hung ^a   Beard, Richard S ^a   Bearden, Shawn E ^a  

^a Nucl Eng Idaho State University   (United States)

Author keywords

Angiogenesis; BEnd.3; Connexin43; Cx43 pS368; Protein kinase C; Wound healing

Indexed keywords

CONNEXIN 43; HOMOCYSTEINE; LIGAND; METABOTROPIC RECEPTOR 5; SHORT HAIRPIN RNA;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; MOLECULAR DOCKING; MOLECULAR INTERACTION; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SIMULATION; TRANSPORT KINETICS; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANIMALS; CELLS, CULTURED; CONNEXIN 43; ENDOTHELIAL CELLS; HOMOCYSTEINE; MICE; MICE, KNOCKOUT; PROTEIN KINASE C; RECEPTORS, METABOTROPIC GLUTAMATE; WOUND HEALING;

EID: 84858161561     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2012.00159.x     Document Type: Article

References (41)

1. Boassa D, Solan JL, Papas A, Thornton P, Lampe PD, Sosinsky GE. Trafficking and recycling of the connexin43 gap junction protein during mitosis. Traffic 11: 1471-1486, 2010.
2. Brauner-Osborne H, Wellendorph P, Jensen AA. Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors. Curr Drug Targets 8: 169-184, 2007.
3. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438: 932-936, 2005.
4. Chopp M, Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol 1: 92-100, 2002.
5. Cina C, Maass K, Theis M, Willecke K, Bechberger JF, Naus CC. Involvement of the cytoplasmic C-terminal domain of connexin43 in neuronal migration. J Neurosci 29: 2009-2021, 2009.
6. Collard CD, Park KA, Montalto MC, Alapati S, Buras JA, Stahl GL, Colgan SP. Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem 277: 14801-14811, 2002.
7. Cooper CD, Solan JL, Dolejsi MK, Lampe PD. Analysis of connexin phosphorylation sites. Methods 20: 196-204, 2000.
8. De Blasi A, Conn PJ, Pin J, Nicoletti F. Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci 22: 114-120, 2001.
9. Debreceni L. Homocysteine: a risk factor for atherosclerosis. Orv Hetil 142: 1439-1444, 2001.
10. Gillard SE, Tzaferis J, Tsui HC, Kingston AE. Expression of metabotropic glutamate receptors in rat meningeal and brain microvasculature and choroid plexus. J Comp Neurol 461: 317-332, 2003.
11. Girelli D, Martinelli N, Olivieri O, Pizzolo F, Friso S, Faccini G, Bozzini C, Tenuti I, Lotto V, Villa G, Guarini P, Trabetti E, Pignatti PF, Mazzucco A, Corrocher R. Hyperhomocysteinemia and mortality after coronary artery bypass grafting. PLoS ONE 1: e83, 2006.
12. Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 58: 731-741, 1976.
13. Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 59: 787-793, 2002.
14. Huang SY, Zou X. Advances and challenges in protein-ligand docking. Int J Mol Sci 11: 3016-3034, 2010.
15. Jamaluddin MD, Chen I, Yang F, Jiang X, Jan M, Liu X, Schafer AI, Durante W, Yang X, Wang H. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood 110: 3648-3655, 2007.
16. Johnstone SR, Best AK, Wright CS, Isakson BE, Errington RJ, Martin PE. Enhanced connexin 43 expression delays intra-mitotic duration and cell cycle traverse independently of gap junction channel function. J Cell Biochem 110: 772-782, 2010.
17. Kalita J, Kumar G, Bansal V, Misra UK. Relationship of homocysteine with other risk factors and outcome of ischemic stroke. Clin Neurol Neurosurg 111: 364-367, 2009.
18. Kretz M, Euwens C, Hombach S, Eckardt D, Teubner B, Traub O, Willecke K, Ott T. Altered connexin expression and wound healing in the epidermis of connexin-deficient mice. J Cell Sci 116: 3443-3452, 2003.
19. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25: 1794-1798, 1994.
20. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407: 971-977, 2000.
21. Kwak BR, Pepper MS, Gros DB, Meda P. Inhibition of endothelial wound repair by dominant negative connexin inhibitors. Mol Biol Cell 12: 831-845, 2001.
22. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 62: 1972-1976, 2004.
23. Martinez-Poveda B, Chavarria T, Sanchez-Jimenez F, Quesada AR, Medina MA. An in vitro evaluation of the effects of homocysteine thiolactone on key steps of angiogenesis and tumor invasion. Biochem Biophys Res Commun 311: 649-653, 2003.
24. Mayo JN, Beard RS Jr, Price TO, Chen CH, Erickson MA, Ercal N, Banks WA, Bearden SE. Nitrative stress in cerebral endothelium is mediated by mGluR5 in hyperhomocysteinemia. J Cereb Blood Flow Metab. 2011. Dec 21. doi: 10.1038/jcbfm.2011.185. [Epub ahead of print].
25. Nagai Y, Tasaki H, Takatsu H, Nihei S, Yamashita K, Toyokawa T, Nakashima Y. Homocysteine inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 281: 726-731, 2001.
26. Nicoletti F, Bockaert J, Collingridge GL, Conn PJ, Ferraguti F, Schoepp DD, Wroblewski JT, Pin JP. Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 60: 1017-1041, 2011.
27. Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 50: 295-322, 2010.
28. Olk S, Turchinovich A, Grzendowski M, Stuhler K, Meyer HE, Zoidl G, Dermietzel R. Proteomic analysis of astroglial connexin43 silencing uncovers a cytoskeletal platform involved in process formation and migration. Glia 58: 494-505, 2010.
29. Olk S, Zoidl G, Dermietzel R. Connexins, cell motility, and the cytoskeleton. Cell Motil Cytoskeleton 66: 1000-1016, 2009.
30. Qiu C, Coutinho P, Frank S, Franke S, Law LY, Martin P, Green CR, Becker DL. Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol 13: 1697-1703, 2003.
31. Rhee DY, Zhao XQ, Francis RJ, Huang GY, Mably JD, Lo CW. Connexin 43 regulates epicardial cell polarity and migration in coronary vascular development. Development 136: 3185-3193, 2009.
32. Richards TS, Dunn CA, Carter WG, Usui ML, Olerud JE, Lampe PD. Protein kinase C spatially and temporally regulates gap junctional communication during human wound repair via phosphorylation of connexin43 on serine368. J Cell Biol 167: 555-562, 2004.
33. Shastry S, Tyagi N, Hayden MR, Tyagi SC. Proteomic analysis of homocysteine inhibition of microvascular endothelial cell angiogenesis. Cell Mol Biol (Noisy-le-grand) 50: 931-937, 2004.
34. Shukla N, Angelini GD, Jeremy JY. Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein. Ann Thorac Surg 84: 43-49, 2007.
35. Sin WC, Bechberger JF, Rushlow WJ, Naus CC. Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells. J Cell Biochem 103: 1772-1782, 2008.
36. Solan JL, Fry MD, TenBroek EM, Lampe PD. Connexin43 phosphorylation at S368 is acute during S and G2/M and in response to protein kinase C activation. J Cell Sci 116: 2203-2211, 2003.
37. Solan JL, Lampe PD. Connexin 43 in LA-25 cells with active v-src is phosphorylated on Y247, Y265, S262, S279/282, and S368 via multiple signaling pathways. Cell Commun Adhes 15: 75-84, 2008.
38. Solan JL, Lampe PD. Connexin43 phosphorylation: structural changes and biological effects. Biochem J 419: 261-272, 2009.
39. Wang H, Jiang X, Yang F, Chapman GB, Durante W, Sibinga NE, Schafer AI. Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition. Blood 99: 939-945, 2002.
40. Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res 4: 143-149, 2007.
41. Zieminska E, Lazarewicz JW. Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors. Acta Neurobiol Exp 66: 301-309, 2006.